1. Denosumab information updated with risk of severe hypocalcaemia

   News item 10 February 2024 Pages: 1 - 1

2. FDA warning about paracetamol overdose and liver damage

   News item 10 February 2024 Pages: 2 - 2

3. FDA warns of risk of eye infections with unapproved eye drops

   News item 10 February 2024 Pages: 3 - 3

4. Finasteride-related self-harm and suicidal ideation

   News item 10 February 2024 Pages: 4 - 4

5. GLP-1-RA shortages: potential for falsified versions

   News item 10 February 2024 Pages: 5 - 5

6. Incorrect medicine (carbinoxamine) in one lot Zenzedi

   News item 10 February 2024 Pages: 6 - 6

7. Warning against use of Artri King tablets

   News item 10 February 2024 Pages: 7 - 7

8. GLP1RAs have no major pharmacokinetic effect on oral medications

   Clinical study 10 February 2024 Pages: 8 - 8

9. Group I pharmaceuticals of IARC: assessing associated cancer risks

   Review 10 February 2024 Pages: 9 - 9

10. ICIs increase risk of ASCVD events in advanced NSCLC

    Clinical study 10 February 2024 Pages: 10 - 10

11. Medication errors relating to clinical guidelines

    Clinical study 10 February 2024 Pages: 11 - 11

12. Other adverse reaction research

    News item 10 February 2024 Pages: 12 - 12

13. Acetazolamide

    Case report 10 February 2024 Pages: 13 - 13

14. Adalimumab/doxycycline/golimumab

    Case report 10 February 2024 Pages: 14 - 14

15. Adalimumab/Prednisolone

    Case report 10 February 2024 Pages: 15 - 15

16. Adefovir-dipivoxil

    Case report 10 February 2024 Pages: 16 - 16

17. Alemtuzumab

    Case report 10 February 2024 Pages: 17 - 17

18. Alendronic-acid/denosumab

    Case report 10 February 2024 Pages: 18 - 18

19. Alpha-ketoglutarate/amino-acids

    Case report 10 February 2024 Pages: 19 - 19

20. Amikacin

    Case report 10 February 2024 Pages: 20 - 20

21. Amiodarone

    Case report 10 February 2024 Pages: 21 - 21

22. Amlodipine

    Case report 10 February 2024 Pages: 22 - 22

23. Amphotericin B liposomal/itraconazole

    Case report 10 February 2024 Pages: 23 - 23

24. Amphotericin-B-liposomal/methotrexate

    Case report 10 February 2024 Pages: 24 - 24

25. Anastrozole

    Case report 10 February 2024 Pages: 25 - 25

26. Angelicae-radix/cnidium-officinale-makino/paeonia/methoxsalen/psoralens

    Case report 10 February 2024 Pages: 26 - 26

27. Anti-inflammatories/corticosteroids/tozinameran

    Case report 10 February 2024 Pages: 27 - 27

28. Antibacterials

    Case report 10 February 2024 Pages: 28 - 28

29. Anticoagulants

    Case report 10 February 2024 Pages: 29 - 29

30. Antiepileptic-drugs

    Case report 10 February 2024 Pages: 30 - 30

31. Antifungals/immunosuppressants

    Case report 10 February 2024 Pages: 31 - 31

32. Antihypertensives/labetalol/magnesium-sulfate

    Case report 10 February 2024 Pages: 32 - 32

33. Antineoplastics

    Case report 10 February 2024 Pages: 33 - 33

34. Antituberculars/levofloxacin

    Case report 10 February 2024 Pages: 34 - 34

35. Asparaginase/pegaspargase

    Case report 10 February 2024 Pages: 35 - 35

36. Aspirin

    Case report 10 February 2024 Pages: 36 - 36

37. Aspirin/Dexamethasone/Hydroxyprogesterone

    Case report 10 February 2024 Pages: 37 - 37

38. Atezolizumab/bevacizumab

    Case report 10 February 2024 Pages: 38 - 38

39. Azathioprine

    Case report 10 February 2024 Pages: 39 - 39

40. AZD-1222/BBIBP-CorV/COVID-19-vaccine-Gamaleya-National-Research-Center-of-Epidemiology-and-Microbiology

    Case report 10 February 2024 Pages: 40 - 40

41. Baricitinib

    Case report 10 February 2024 Pages: 41 - 41

42. Baricitinib/etanercept/tocilizumab

    Case report 10 February 2024 Pages: 42 - 42

43. BCG-vaccine

    Case report 10 February 2024 Pages: 43 - 43

44. Beraprost/Mecobalamin

    Case report 10 February 2024 Pages: 44 - 44

45. Bivalirudin/Heparin

    Case report 10 February 2024 Pages: 45 - 45

46. Bleomycin/cisplatin/etoposide

    Case report 10 February 2024 Pages: 46 - 46

47. Bleomycin/Cisplatin/Vincristine

    Case report 10 February 2024 Pages: 47 - 47

48. Blinatumomab

    Case report 10 February 2024 Pages: 48 - 48

49. Cabozantinib

    Case report 10 February 2024 Pages: 49 - 49

50. Calcitriol/Calcium-carbonate

    Case report 10 February 2024 Pages: 50 - 50